Slim chance in the pharma dance
|
|
Overview
Your client, MedEx Innovations, is preparing to launch Slimvora, a GLP-1 weight loss drug expected to compete with Ozempic and Wegovy. After investing $8 billion in development, MedEx has hired your firm to design a launch strategy that maximizes return on investment and captures untapped market demand.
Formats available
📄 Peer practice PDF
🎥 Expert video
Case info
Difficulty
Intermediate
Industry
Healthcare, pharmaceuticals and medical devices
Case type
Market entry
Geography
North America, USA
Additional info
Includes charts and/or data analysis
Video mock interview with Experts
Tip: Try cases on your own before watching Expert videos to maximize learning.
Featured Experts
Director at Alvarez & Marsal | ex-EY-P
Strategy & Development Manager - Energy Infrastructure
P.S. Are you preparing for consulting interviews?
Real interview drills. Sample answers from ex-McKinsey, BCG and Bain consultants. Plus technique overviews and premium 1-on-1 Expert coaching.
